n ras Search Results


92
Cytoskeleton Inc recombinant protein

Recombinant Protein, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc07909951-46-1-6?v=Cytoskeleton+Inc
Average 92 stars, based on 1 article reviews
recombinant protein - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology n ras

N Ras, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/10__1128_slash_jvi__79__14__8742___8749__2005-84-12-13?v=Santa+Cruz+Biotechnology
Average 91 stars, based on 1 article reviews
n ras - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology nras

Nras, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc07843419__41388_2020_1567_MOESM1_ESM-6-8-17?v=Santa+Cruz+Biotechnology
Average 95 stars, based on 1 article reviews
nras - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

92
Addgene inc mutant n ras 61k

Mutant N Ras 61k, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/10__1158_slash_1541___7786__mcr___13___0663-63-3-9?v=Addgene+inc
Average 92 stars, based on 1 article reviews
mutant n ras 61k - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

93
Proteintech anti nras

Anti Nras, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc08458072__gutjnl___2020___322779supp002-69-10-12?v=Proteintech
Average 93 stars, based on 1 article reviews
anti nras - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

91
Addgene inc donor nras 12d open reading frame plasmid

Donor Nras 12d Open Reading Frame Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/bio_rxiv__2020__03__22__002774-87-11-18?v=Addgene+inc
Average 91 stars, based on 1 article reviews
donor nras 12d open reading frame plasmid - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

91
Addgene inc plex uorf ha bira n ras q61k t35a ires puro

Plex Uorf Ha Bira N Ras Q61k T35a Ires Puro, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc06386588-163-0-5?v=Addgene+inc
Average 91 stars, based on 1 article reviews
plex uorf ha bira n ras q61k t35a ires puro - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

93
Proteintech csde1 affinity df12920 wb

Csde1 Affinity Df12920 Wb, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc08983694__41420_2022_992_MOESM1_ESM-25-15-7?v=Proteintech
Average 93 stars, based on 1 article reviews
csde1 affinity df12920 wb - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

92
Addgene inc pcgn nraswt addgene

Pcgn Nraswt Addgene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pm30712867-268-13-15?v=Addgene+inc
Average 92 stars, based on 1 article reviews
pcgn nraswt addgene - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

90
Proteintech c2c12 cells expressing gfp2 k ras
(A) Confocal images of <t>C2C12</t> cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.
C2c12 Cells Expressing Gfp2 K Ras, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/bio_rxiv__64898__2026__03__05__709789-273-6-20?v=Proteintech
Average 90 stars, based on 1 article reviews
c2c12 cells expressing gfp2 k ras - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriGene n ras plasmid
(A) Confocal images of <t>C2C12</t> cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.
N Ras Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pm24861879-79-40-42?v=OriGene
Average 90 stars, based on 1 article reviews
n ras plasmid - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Addgene inc pcgn nras 12d plasmid
(A) Confocal images of <t>C2C12</t> cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.
Pcgn Nras 12d Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/n+ras/pmc05377799-978-2-6?v=Addgene+inc
Average 90 stars, based on 1 article reviews
pcgn nras 12d plasmid - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Journal: eLife

Article Title: Complex structures of Rsu1 and PINCH1 reveal a regulatory mechanism of the ILK/PINCH/Parvin complex for F-actin dynamics

doi: 10.7554/eLife.64395

Figure Lengend Snippet:

Article Snippet: Peptide, recombinant protein , actin , Cytoskeleton, Inc , Cat. # AKL99 , Rabbit Skeletal Muscle.

Techniques: Recombinant, Expressing, Transfection, Staining, Western Blot, Software

(A) Confocal images of C2C12 cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.

Journal: bioRxiv

Article Title: K-Ras controls asymmetric cell divisions from the primary cilium

doi: 10.64898/2026.03.05.709789

Figure Lengend Snippet: (A) Confocal images of C2C12 cells grown in high serum for 72 h and immunolabelled for Pax7 in the nucleus and ciliary marker Arl13B. Phalloidin staining visualizes cell outlines. Scale bar = 20 µm. (B) Quantification of ciliation using data as in (A), N = 3 independent biological repeats with a total of n = 800 cells. Means ± SD are plotted. Statistical analysis was done with the unpaired t-test. ( C-F ) Modelled (curves) and measured (points) of the population evolution of MuSC, TAC and differentiated C2C12 cells (Diff) after serum switching at day 0 to trigger differentiation. Experimental samples were treated at day -1 with non-targeting siRNA (siCTRL, C), siRNA targeting KRAS4A/4B (si-pan KRAS, D), NRAS (E) or HRAS (F). Plots to the right show predicted percentage of ciliated cells over time with the line indicating day 3 in differentiating low serum. (G) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated siRNA (100 nM) and grown in low serum for 72 h. N = 3, n > 500. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and the Dunnett’s T3 multiple comparisons test. (H) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 treated as in (G), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.

Article Snippet: To visualize K-Ras with STED microscopy, C2C12 cells expressing GFP2-K-Ras were fixed with 4 % (w/v) paraformaldehyde and immunolabelled with ChromoTek GFP-booster ATTO647N.

Techniques: Marker, Staining, Imaging, Transfection, Expressing

( A-C ) Confocal images of C2C12 cells grown in high serum for 48 h after transfection with GFP2-K-Ras (A, n = 73), GFP2-N-Ras (B, n = 48) or GFP2-H-Ras (C, n = 47) and immunolabeled for ciliary marker Arl13B (arrow). Bottom , images show orthogonal views. Scale bar = 10 µm. (D) Quantification of Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) using data as in (A-C), N = 3. Means ± SD are plotted. Statistical comparison was done against K-Ras with the Kruskal-Wallis test and Dunn’s post hoc test. (E) Confocal images of C2C12 cells treated with PDE6D-targeting siRNA (100 nM), transfected with GFP2-K-Ras and cultured thereafter for 48 h in high serum. Scale bar = 10 µm. (F) Quantification of K-Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) using data as in (E), N = 3; siCTRL, n = 30; si PDE6D , n = 30. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. (G) Confocal images of C2C12-mEos3.2-KRAS knock-in cells cultured in high serum for 24 h directly after FACS-sorting and immunolabelled for ciliary marker Arl13B and centriolar marker γ-tubulin. Scale bar = 10 µm.

Journal: bioRxiv

Article Title: K-Ras controls asymmetric cell divisions from the primary cilium

doi: 10.64898/2026.03.05.709789

Figure Lengend Snippet: ( A-C ) Confocal images of C2C12 cells grown in high serum for 48 h after transfection with GFP2-K-Ras (A, n = 73), GFP2-N-Ras (B, n = 48) or GFP2-H-Ras (C, n = 47) and immunolabeled for ciliary marker Arl13B (arrow). Bottom , images show orthogonal views. Scale bar = 10 µm. (D) Quantification of Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) using data as in (A-C), N = 3. Means ± SD are plotted. Statistical comparison was done against K-Ras with the Kruskal-Wallis test and Dunn’s post hoc test. (E) Confocal images of C2C12 cells treated with PDE6D-targeting siRNA (100 nM), transfected with GFP2-K-Ras and cultured thereafter for 48 h in high serum. Scale bar = 10 µm. (F) Quantification of K-Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) using data as in (E), N = 3; siCTRL, n = 30; si PDE6D , n = 30. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. (G) Confocal images of C2C12-mEos3.2-KRAS knock-in cells cultured in high serum for 24 h directly after FACS-sorting and immunolabelled for ciliary marker Arl13B and centriolar marker γ-tubulin. Scale bar = 10 µm.

Article Snippet: To visualize K-Ras with STED microscopy, C2C12 cells expressing GFP2-K-Ras were fixed with 4 % (w/v) paraformaldehyde and immunolabelled with ChromoTek GFP-booster ATTO647N.

Techniques: Transfection, Immunolabeling, Marker, Clinical Proteomics, Membrane, Comparison, Cell Culture, MANN-WHITNEY, Knock-In

(A) Confocal images of C2C12 cells grown in high serum for 24 h after transfection with mEGFP-K-Ras. Images were acquired before (-1 s) and after (1 – 4 s) photobleaching at 0 s. Images represent the 10 µm × 10 µm photobleached region. FRAP was monitored at the ciliary tip (arrowhead) and wider base (arrow). Scale bar = 4 µm. (B) Recovery curves for tip and base using data as in (A). Mean ± SEM of fluorescence intensities from all cells per time point, N = 3, n = 23 per condition. ( C , D ) Analysis of individual FRAP curves summarized in (B) yielded diffusion coefficient (C; N = 3, n = 15) and mobile fraction (D; N = 3, n = 23) at ciliary tip and base. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. ( E, F ) STED images of C2C12 cells grown in high serum for 48 h after transfection with GFP2-K-Ras and immunolabeled for GFP using an ATTO647N-conjugated nanobody and ciliary membrane marker Arl13B or centriolar marker γ-tubulin. Position of the cilium (arrowhead) relative to the centrioles (arrow) is indicated. Scale bar = 2 µm. ( G, H ) Confocal images of C2C12 cells grown in high serum for 48 h. Cells were not transfected with K-Ras constructs, but with GFP2-B-Raf (G) and immunolabelled for acetylated α-tubulin marking the cilium (G; N = 3, n = 50) or immunolabelled for endogenous phospho-S217/S221-MEK1/2 and acetylated α-tubulin to mark the cilium (H; N = 3, n = 50). Scale bar = 2 µm.

Journal: bioRxiv

Article Title: K-Ras controls asymmetric cell divisions from the primary cilium

doi: 10.64898/2026.03.05.709789

Figure Lengend Snippet: (A) Confocal images of C2C12 cells grown in high serum for 24 h after transfection with mEGFP-K-Ras. Images were acquired before (-1 s) and after (1 – 4 s) photobleaching at 0 s. Images represent the 10 µm × 10 µm photobleached region. FRAP was monitored at the ciliary tip (arrowhead) and wider base (arrow). Scale bar = 4 µm. (B) Recovery curves for tip and base using data as in (A). Mean ± SEM of fluorescence intensities from all cells per time point, N = 3, n = 23 per condition. ( C , D ) Analysis of individual FRAP curves summarized in (B) yielded diffusion coefficient (C; N = 3, n = 15) and mobile fraction (D; N = 3, n = 23) at ciliary tip and base. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. ( E, F ) STED images of C2C12 cells grown in high serum for 48 h after transfection with GFP2-K-Ras and immunolabeled for GFP using an ATTO647N-conjugated nanobody and ciliary membrane marker Arl13B or centriolar marker γ-tubulin. Position of the cilium (arrowhead) relative to the centrioles (arrow) is indicated. Scale bar = 2 µm. ( G, H ) Confocal images of C2C12 cells grown in high serum for 48 h. Cells were not transfected with K-Ras constructs, but with GFP2-B-Raf (G) and immunolabelled for acetylated α-tubulin marking the cilium (G; N = 3, n = 50) or immunolabelled for endogenous phospho-S217/S221-MEK1/2 and acetylated α-tubulin to mark the cilium (H; N = 3, n = 50). Scale bar = 2 µm.

Article Snippet: To visualize K-Ras with STED microscopy, C2C12 cells expressing GFP2-K-Ras were fixed with 4 % (w/v) paraformaldehyde and immunolabelled with ChromoTek GFP-booster ATTO647N.

Techniques: Transfection, Fluorescence, Diffusion-based Assay, MANN-WHITNEY, Immunolabeling, Membrane, Marker, Construct

(A) BRET titration curve of Rluc8-PDE6D and GFP2-K-Ras-SI as compared to GFP2-K-Ras expressed in HEK cells, N = 3. Means ± SD are plotted. Statistical analysis was performed with the extra sum-of-squares F-test. ( B, C ) Confocal images of C2C12 cells grown in low serum for 72 h after transfection with mEGFP-K-Ras (top) or mEGFP-K-Ras-SI (bottom) and immunolabelled for ciliary markers (arrows) Arl13B (B) or acetylated α-tubulin (C). The mCherry-PDE6D construct was co-expressed at 1:1 DNA ratio with K-Ras variant constructs (C). Scale = 10 µm. (D) Quantification of Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) per cell using data as in (B,C), N = 3, mEGFP-K-Ras, n = 31; mEGFP-K-Ras-SI, n = 31. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. (E) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated mEGFP-tagged K-Ras constructs and cultured for 72 h in low serum. The mCherry-PDE6D construct was co-expressed at 1:1 DNA ratio with K-Ras variant constructs as indicated, N = 3, n ≥ 200 per condition. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test. (F) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 cells grown in low serum for 72 h after transfection with mEGFP-tagged K-Ras variant constructs alone or co-transfected with mCherry-PDE6D as in (E), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.

Journal: bioRxiv

Article Title: K-Ras controls asymmetric cell divisions from the primary cilium

doi: 10.64898/2026.03.05.709789

Figure Lengend Snippet: (A) BRET titration curve of Rluc8-PDE6D and GFP2-K-Ras-SI as compared to GFP2-K-Ras expressed in HEK cells, N = 3. Means ± SD are plotted. Statistical analysis was performed with the extra sum-of-squares F-test. ( B, C ) Confocal images of C2C12 cells grown in low serum for 72 h after transfection with mEGFP-K-Ras (top) or mEGFP-K-Ras-SI (bottom) and immunolabelled for ciliary markers (arrows) Arl13B (B) or acetylated α-tubulin (C). The mCherry-PDE6D construct was co-expressed at 1:1 DNA ratio with K-Ras variant constructs (C). Scale = 10 µm. (D) Quantification of Ras signal in the primary cilium (PC) as compared to the plasma membrane (PM) per cell using data as in (B,C), N = 3, mEGFP-K-Ras, n = 31; mEGFP-K-Ras-SI, n = 31. Means ± SD are plotted. Statistical analysis was done with the Mann-Whitney test. (E) Confocal imaging-based quantification of ciliation of C2C12 transfected with the indicated mEGFP-tagged K-Ras constructs and cultured for 72 h in low serum. The mCherry-PDE6D construct was co-expressed at 1:1 DNA ratio with K-Ras variant constructs as indicated, N = 3, n ≥ 200 per condition. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test. (F) Flow cytometric quantification of MyHC terminal differentiation marker expression in C2C12 cells grown in low serum for 72 h after transfection with mEGFP-tagged K-Ras variant constructs alone or co-transfected with mCherry-PDE6D as in (E), N = 3. Means ± SD are plotted. Statistical analysis was done with one-way ANOVA and Dunnett’s T3 multiple comparisons test.

Article Snippet: To visualize K-Ras with STED microscopy, C2C12 cells expressing GFP2-K-Ras were fixed with 4 % (w/v) paraformaldehyde and immunolabelled with ChromoTek GFP-booster ATTO647N.

Techniques: Titration, Transfection, Construct, Variant Assay, Clinical Proteomics, Membrane, MANN-WHITNEY, Imaging, Cell Culture, Marker, Expressing